Increased breath ethane levels in medicated patients with schizophrenia and bipolar disorder are unrelated to erythrocyte omega-3 fatty acid abundance.
Oxidative stress has been reported to be elevated in mental illness. Preliminary evidence suggests this phenomenon can be assessed non-invasively by determining breath levels of the omega-3 polyunsaturated fatty acid (PUFA) oxidation product ethane. This study compares alkane levels in chronic, medicated, patients with schizophrenia or bipolar disorder with those in healthy controls. Both ethane and butane levels were significantly increased in patients with schizophrenia or bipolar disorder, although elevated butane levels were likely due to increased ambient gas concentrations. Ethane levels were not correlated with symptom severity or with erythrocyte omega-3 PUFA levels. Our results support the hypothesis that oxidative stress is elevated in patients with schizophrenia and bipolar disorder leading to increased breath ethane abundance. This does not appear to be caused by increased abundance of omega-3 PUFA, but rather is likely due to enhanced oxidative damage of these lipids. As such, breath hydrocarbon analysis may represent a simple, non-invasive means to monitor the metabolic processes occurring in these disorders.
Northern Ontario School of Medicine, Lakehead University, Thunder Bay, Ontario, Canada.
Brian M
BM
Ross
Ross
R
Maxwell
Iain
I
Glen
D001714:Bipolar Disorder / Q000188:drug therapy / Q000378:metabolism*; D001944:Breath Tests; D002073:Butanes / Q000032:analysis*; D004912:Erythrocytes / Q000737:chemistry / Q000378:metabolism; D004980:Ethane / Q000032:analysis*; D015525:Fatty Acids, Omega-3 / Q000097:blood* / Q000737:chemistry / Q000378:metabolism; D005260:Female; D006801:Humans; D008297:Male; D010084:Oxidation-Reduction; D018384:Oxidative Stress; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy / Q000378:metabolism*
D002073:Butanes; D015525:Fatty Acids, Omega-3; C046888:butane; D004980:Ethane